methamphetamine has been researched along with sincalide in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fukamauchi, F; Kaneno, S; Shibuya, H; Takahashi, R; Yoshikawa, T | 2 |
| Hsiao, S; Itoh, S; Katsuura, G | 1 |
| Itoh, S; Katsuura, G | 1 |
| Baba, A; Hori, T; Kawai, N; Koizumi, J; Moroji, T; Suzuki, T | 1 |
| Fukumaki, Y; Hamamura, M; Ozaki, M; Ozawa, H; Shimazoe, T; Terada, Y | 1 |
| Gao, R; Jiang, L; Liu, J; Qian, W; Wang, J; Xiao, H; Yu, P; Zhao, J; Zhou, J | 1 |
| Cong, B; Gou, H; Li, M; Li, Y; Liu, L; Ma, C; Wen, D; Zhang, W | 1 |
| An, M; Cong, B; Gou, H; Liu, L; Liu, X; Ma, C; Wen, D | 1 |
| An, M; Cong, B; Gou, H; Hao, L; Ma, C; Sun, D; Wen, D; Xie, B | 1 |
| Bi, HT; Cong, B; Jing, WW; Ma, CL; Wen, D; Xie, B; Yu, F; Zhang, ML; Zhang, WH | 1 |
1 review(s) available for methamphetamine and sincalide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for methamphetamine and sincalide
| Article | Year |
|---|---|
Dopaminergic agents affected neuronal transmission of cholecystokinin in the rat brain.
Topics: Animals; Brain; Haloperidol; Immune Sera; Male; Methamphetamine; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide; Synaptic Transmission | 1987 |
The chronic administration of dopamine antagonists and methamphetamine changed the [3H]-cholecystokinin-8 binding sites in the rat frontal cortex.
Topics: Animals; Dopamine Antagonists; Frontal Lobe; In Vitro Techniques; Kinetics; Male; Methamphetamine; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Sincalide; Tritium | 1987 |
Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
Topics: Animals; Apomorphine; Brain; Dopamine; Gastrins; Hydroxydopamines; Male; Methamphetamine; Motor Activity; Oxidopamine; Proglumide; Rats; Rats, Inbred Strains; Sincalide; Tetragastrin | 1985 |
Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
Topics: Animals; Behavior, Animal; Brain; Ceruletide; Cholecystokinin; Dose-Response Relationship, Drug; Ethanol; Hypnotics and Sedatives; Male; Methamphetamine; Motor Activity; Pentobarbital; Peptide Fragments; Rats; Rats, Inbred Strains; Sincalide; Sleep; Thyrotropin-Releasing Hormone | 1982 |
Autoradiographic localization of CCK-8 binding sites in the rat brain: effects of chronic methamphetamine administration on these sites.
Topics: Animals; Autoradiography; Brain; Male; Methamphetamine; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide | 1993 |
Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.
Topics: Analysis of Variance; Animals; Blotting, Northern; Capsaicin; Cerebellum; In Situ Hybridization; Methamphetamine; Mice; Nerve Fibers; Neurons; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger; Sincalide; Statistics, Nonparametric; Transcription Factors | 2010 |
Effect of methamphetamine on the microglial damage: role of potassium channel Kv1.3.
Topics: 4-Aminopyridine; Amines; Animals; Central Nervous System Stimulants; Female; In Situ Nick-End Labeling; Interleukin-6; Kv1.3 Potassium Channel; Methamphetamine; Microglia; Nitric Oxide Synthase Type II; Patch-Clamp Techniques; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Scorpion Venoms; Sincalide; Tetraethylammonium; Tumor Necrosis Factor-alpha | 2014 |
Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
Topics: Amphetamine-Related Disorders; Animals; Body Temperature; Cholecystokinin; Corpus Striatum; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Male; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Peptide Fragments; Random Allocation; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase | 2015 |
Cholecystokinin-8 inhibits methamphetamine-induced neurotoxicity via an anti-oxidative stress pathway.
Topics: Animals; Cell Survival; Central Nervous System Stimulants; Chemokines, CC; Cholecystokinin; Gene Expression Regulation; HEK293 Cells; Humans; Malondialdehyde; Methamphetamine; NADPH Oxidases; Oxidative Stress; PC12 Cells; Peptide Fragments; Rats; Reactive Oxygen Species; Receptor, Cholecystokinin B; RNA, Small Interfering; Signal Transduction; Time Factors; Transfection | 2016 |
Cholecystokinin-8 attenuates methamphetamine-induced inflammatory activation of microglial cells through CCK2 receptor.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Central Nervous System Stimulants; Cholecystokinin; Inflammation Mediators; Interleukin-6; Methamphetamine; Mice; Microglia; NF-kappa B; Peptide Fragments; Receptor, Cholecystokinin B; Signal Transduction; Tumor Necrosis Factor-alpha | 2020 |
Inhibitory Effect of CCK-8 on Methamphetamine-Induced Apoptosis.
Topics: Apoptosis; Central Nervous System Stimulants; HEK293 Cells; Humans; Methamphetamine; Sincalide | 2021 |